Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Sep;70(9):5860–5866. doi: 10.1128/jvi.70.9.5860-5866.1996

Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme.

F Petit 1, S Bertagnoli 1, J Gelfi 1, F Fassy 1, C Boucraut-Baralon 1, A Milon 1
PMCID: PMC190603  PMID: 8709205

Abstract

A genomic library of myxoma virus (MV) DNA, a leporipoxvirus that causes myxomatosis, was constructed and screened by in vitro transcription-translation. A clone was selected on the basis of its strong reactivity with MV antiserum. Analysis of the corresponding DNA sequence and the deduced amino acid sequence revealed an open reading frame coding for a 34-kDa protein with strong homologies to members of the serpin superfamily. The gene encoding this new protein, called serp2, was localized on the MV genome. Interestingly, this gene is deleted in an attenuated strain. We constructed a baculovirus vector to produce recombinant Serp2 protein and raised specific antisera that allowed the characterization of Serp2 expression during the MV cycle. The biological relevance of this new serpin from MV was monitored, and it was shown that Serp2 could inhibit human interleukin-1 beta-converting enzyme activity.

Full Text

The Full Text of this article is available as a PDF (657.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcamí A., Smith G. L. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 1992 Oct 2;71(1):153–167. doi: 10.1016/0092-8674(92)90274-g. [DOI] [PubMed] [Google Scholar]
  2. Alcamí A., Smith G. L. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today. 1995 Oct;16(10):474–478. doi: 10.1016/0167-5699(95)80030-1. [DOI] [PubMed] [Google Scholar]
  3. Ali A. N., Turner P. C., Brooks M. A., Moyer R. W. The SPI-1 gene of rabbitpox virus determines host range and is required for hemorrhagic pock formation. Virology. 1994 Jul;202(1):305–314. doi: 10.1006/viro.1994.1347. [DOI] [PubMed] [Google Scholar]
  4. Brooks M. A., Ali A. N., Turner P. C., Moyer R. W. A rabbitpox virus serpin gene controls host range by inhibiting apoptosis in restrictive cells. J Virol. 1995 Dec;69(12):7688–7698. doi: 10.1128/jvi.69.12.7688-7698.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carrell R. W., Pemberton P. A., Boswell D. R. The serpins: evolution and adaptation in a family of protease inhibitors. Cold Spring Harb Symp Quant Biol. 1987;52:527–535. doi: 10.1101/sqb.1987.052.01.060. [DOI] [PubMed] [Google Scholar]
  6. Drillien R., Spehner D., Villeval D., Lecocq J. P. Similar genetic organization between a region of fowlpox virus DNA and the vaccinia virus HindIII J fragment despite divergent location of the thymidine kinase gene. Virology. 1987 Sep;160(1):203–209. doi: 10.1016/0042-6822(87)90061-4. [DOI] [PubMed] [Google Scholar]
  7. Gagliardini V., Fernandez P. A., Lee R. K., Drexler H. C., Rotello R. J., Fishman M. C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 1994 Feb 11;263(5148):826–828. doi: 10.1126/science.8303301. [DOI] [PubMed] [Google Scholar]
  8. Gettins P., Patston P. A., Schapira M. The role of conformational change in serpin structure and function. Bioessays. 1993 Jul;15(7):461–467. doi: 10.1002/bies.950150705. [DOI] [PubMed] [Google Scholar]
  9. Graham K. A., Opgenorth A., Upton C., McFadden G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virology. 1992 Nov;191(1):112–124. doi: 10.1016/0042-6822(92)90172-l. [DOI] [PubMed] [Google Scholar]
  10. Hill R. E., Hastie N. D. Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature. 1987 Mar 5;326(6108):96–99. doi: 10.1038/326096a0. [DOI] [PubMed] [Google Scholar]
  11. Hill R. E., Shaw P. H., Boyd P. A., Baumann H., Hastie N. D. Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions. Nature. 1984 Sep 13;311(5982):175–177. doi: 10.1038/311175a0. [DOI] [PubMed] [Google Scholar]
  12. Howard A. D., Kostura M. J., Thornberry N., Ding G. J., Limjuco G., Weidner J., Salley J. P., Hogquist K. A., Chaplin D. D., Mumford R. A. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol. 1991 Nov 1;147(9):2964–2969. [PubMed] [Google Scholar]
  13. Hu F. Q., Smith C. A., Pickup D. J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology. 1994 Oct;204(1):343–356. doi: 10.1006/viro.1994.1539. [DOI] [PubMed] [Google Scholar]
  14. Isaacs S. N., Kotwal G. J., Moss B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):628–632. doi: 10.1073/pnas.89.2.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kettle S., Blake N. W., Law K. M., Smith G. L. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology. 1995 Jan 10;206(1):136–147. doi: 10.1016/s0042-6822(95)80028-x. [DOI] [PubMed] [Google Scholar]
  16. Komiyama T., Ray C. A., Pickup D. J., Howard A. D., Thornberry N. A., Peterson E. P., Salvesen G. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem. 1994 Jul 29;269(30):19331–19337. [PubMed] [Google Scholar]
  17. Kordula T., Dubin A., Schooltink H., Koj A., Heinrich P. C., Rose-John S. Molecular cloning and expression of an intracellular serpin: an elastase inhibitor from horse leucocytes. Biochem J. 1993 Jul 1;293(Pt 1):187–193. doi: 10.1042/bj2930187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Law K. M., Smith G. L. A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. J Gen Virol. 1992 Mar;73(Pt 3):549–557. doi: 10.1099/0022-1317-73-3-549. [DOI] [PubMed] [Google Scholar]
  19. Lomas D. A., Evans D. L., Upton C., McFadden G., Carrell R. W. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem. 1993 Jan 5;268(1):516–521. [PubMed] [Google Scholar]
  20. Macen J. L., Upton C., Nation N., McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology. 1993 Aug;195(2):348–363. doi: 10.1006/viro.1993.1385. [DOI] [PubMed] [Google Scholar]
  21. Massung R. F., Jayarama V., Moyer R. W. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology. 1993 Dec;197(2):511–528. doi: 10.1006/viro.1993.1625. [DOI] [PubMed] [Google Scholar]
  22. McFadden G., Graham K., Ellison K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J Leukoc Biol. 1995 May;57(5):731–738. doi: 10.1002/jlb.57.5.731. [DOI] [PubMed] [Google Scholar]
  23. McKenzie R., Kotwal G. J., Moss B., Hammer C. H., Frank M. M. Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis. 1992 Dec;166(6):1245–1250. doi: 10.1093/infdis/166.6.1245. [DOI] [PubMed] [Google Scholar]
  24. Odake S., Kam C. M., Narasimhan L., Poe M., Blake J. T., Krahenbuhl O., Tschopp J., Powers J. C. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry. 1991 Feb 26;30(8):2217–2227. doi: 10.1021/bi00222a027. [DOI] [PubMed] [Google Scholar]
  25. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol. 1992 Aug;66(8):4720–4731. doi: 10.1128/jvi.66.8.4720-4731.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Opgenorth A., Strayer D., Upton C., McFadden G. Deletion of the growth factor gene related to EGF and TGF alpha reduces virulence of malignant rabbit fibroma virus. Virology. 1992 Jan;186(1):175–191. doi: 10.1016/0042-6822(92)90072-w. [DOI] [PubMed] [Google Scholar]
  27. Palumbo G. J., Buller R. M., Glasgow W. C. Multigenic evasion of inflammation by poxviruses. J Virol. 1994 Mar;68(3):1737–1749. doi: 10.1128/jvi.68.3.1737-1749.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pickup D. J., Ink B. S., Hu W., Ray C. A., Joklik W. K. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7698–7702. doi: 10.1073/pnas.83.20.7698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Quan L. T., Caputo A., Bleackley R. C., Pickup D. J., Salvesen G. S. Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem. 1995 May 5;270(18):10377–10379. doi: 10.1074/jbc.270.18.10377. [DOI] [PubMed] [Google Scholar]
  30. Ray C. A., Black R. A., Kronheim S. R., Greenstreet T. A., Sleath P. R., Salvesen G. S., Pickup D. J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell. 1992 May 15;69(4):597–604. doi: 10.1016/0092-8674(92)90223-y. [DOI] [PubMed] [Google Scholar]
  31. Russell R. J., Robbins S. J. Cloning and molecular characterization of the myxoma virus genome. Virology. 1989 May;170(1):147–159. doi: 10.1016/0042-6822(89)90362-0. [DOI] [PubMed] [Google Scholar]
  32. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shi L., Kam C. M., Powers J. C., Aebersold R., Greenberg A. H. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med. 1992 Dec 1;176(6):1521–1529. doi: 10.1084/jem.176.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sleath P. R., Hendrickson R. C., Kronheim S. R., March C. J., Black R. A. Substrate specificity of the protease that processes human interleukin-1 beta. J Biol Chem. 1990 Aug 25;265(24):14526–14528. [PubMed] [Google Scholar]
  35. Smith C. A., Davis T., Wignall J. M., Din W. S., Farrah T., Upton C., McFadden G., Goodwin R. G. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun. 1991 Apr 15;176(1):335–342. doi: 10.1016/0006-291x(91)90929-2. [DOI] [PubMed] [Google Scholar]
  36. Smith G. L., Howard S. T., Chan Y. S. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. J Gen Virol. 1989 Sep;70(Pt 9):2333–2343. doi: 10.1099/0022-1317-70-9-2333. [DOI] [PubMed] [Google Scholar]
  37. Smith G. L. Vaccinia virus glycoproteins and immune evasion. The sixteenth Fleming Lecture. J Gen Virol. 1993 Sep;74(Pt 9):1725–1740. doi: 10.1099/0022-1317-74-9-1725. [DOI] [PubMed] [Google Scholar]
  38. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M., VanSlyke J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell. 1992 Oct 2;71(1):145–152. doi: 10.1016/0092-8674(92)90273-f. [DOI] [PubMed] [Google Scholar]
  39. Symons J. A., Alcamí A., Smith G. L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 1995 May 19;81(4):551–560. doi: 10.1016/0092-8674(95)90076-4. [DOI] [PubMed] [Google Scholar]
  40. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995 Jun 2;81(5):801–809. doi: 10.1016/0092-8674(95)90541-3. [DOI] [PubMed] [Google Scholar]
  41. Tewari M., Telford W. G., Miller R. A., Dixit V. M. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem. 1995 Sep 29;270(39):22705–22708. doi: 10.1074/jbc.270.39.22705. [DOI] [PubMed] [Google Scholar]
  42. Thompson J. P., Turner P. C., Ali A. N., Crenshaw B. C., Moyer R. W. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. Virology. 1993 Nov;197(1):328–338. doi: 10.1006/viro.1993.1594. [DOI] [PubMed] [Google Scholar]
  43. Turner P. C., Moyer R. W. An orthopoxvirus serpinlike gene controls the ability of infected cells to fuse. J Virol. 1992 Apr;66(4):2076–2085. doi: 10.1128/jvi.66.4.2076-2085.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Upton C., Macen J. L., McFadden G. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol. 1987 Apr;61(4):1271–1275. doi: 10.1128/jvi.61.4.1271-1275.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Upton C., Macen J. L., Schreiber M., McFadden G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 1991 Sep;184(1):370–382. doi: 10.1016/0042-6822(91)90853-4. [DOI] [PubMed] [Google Scholar]
  46. Upton C., Macen J. L., Wishart D. S., McFadden G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology. 1990 Dec;179(2):618–631. doi: 10.1016/0042-6822(90)90129-f. [DOI] [PubMed] [Google Scholar]
  47. Upton C., McFadden G. Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol. 1986 Dec;60(3):920–927. doi: 10.1128/jvi.60.3.920-927.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Upton C., McFadden G. Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology. 1986 Jul 30;152(2):308–321. doi: 10.1016/0042-6822(86)90134-0. [DOI] [PubMed] [Google Scholar]
  49. Upton C., Mossman K., McFadden G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science. 1992 Nov 20;258(5086):1369–1372. doi: 10.1126/science.1455233. [DOI] [PubMed] [Google Scholar]
  50. Upton C., Opgenorth A., Traktman P., McFadden G. Identification and DNA sequence of the Shope fibroma virus DNA topoisomerase gene. Virology. 1990 Jun;176(2):439–447. doi: 10.1016/0042-6822(90)90013-h. [DOI] [PubMed] [Google Scholar]
  51. Zhou J., Sun X. Y., Fernando G. J., Frazer I. H. The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology. 1992 Aug;189(2):678–686. doi: 10.1016/0042-6822(92)90591-c. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES